Small companies

This study "Sustained product innovation in small companies through the lens of absorptive capacity" conducts qualitative and quantitative research into the ability of small companies to acquire and exploit new knowledge (absorptive capacity) and how this capability together with organisational processes, resources, capabilities and characteristics influence the front-end of the product innovation process; and how this in turn impacts on successful and sustained product innovation, in the context of small food manufacturing companies in Australia.

203p runthenight04 02-02-2023 13 3   Download

Researching on factors affecting human resource development: In case of the small and medium companies in the Trade and Service sector in Tra Vinh province, in order to analyse, evaluate and make new contributions to the theoretical base, on the basis of which proposes governance implications to perfect the admission factors to human resource development of SMCs, contributing to improving the performance of local businesses.

27p closefriend08 10-11-2021 17 5   Download

The second essay examines the effect of banking system reform, which is defined by the presence of foreign banks, on investment-cash flow relation in a context of a small transition economy. I find evidence that the presence of foreign banks in Vietnam results in decreasing in firm’s dependence on local banks and has changed their financial constraint. Company investments are less reliant on internal cash flow in the post reform period.

178p kequaidan6 15-07-2020 28 2   Download

The thesis proposes opinions, solutions and recommendations to improve the organisation of auditing construction companies’ financial statement for small and medium audit firms in Vietnam.

33p quenchua 28-09-2019 44 5   Download

I. Errors 6. Despite the house was small and old, it was in good condition. A B C D 7. Hoa, who is my oldest sister, has been working for Prudential Insurance Company for nearly 5 years. A ...

7p neyugnmall001 24-08-2012 134 20   Download

It happens all the time: a pharmaceutical or biotechnology company will spend ten years and hundreds of millions of dollars on a drug candidate that looks spectacular in animal models of a disease, only to see it fail during clinical trials, either because of unexpected adverse reactions in a small number of patients or a surprising lack of efficacy. For every drug that is approved, on average more than 6,000 new chemical substances are created. Only seven of these ever end up being tested in humans, and only three make it to Phase III clinical trials, the final step before...

0p thulanh21 15-11-2011 51 2   Download